YU47100A - Novi derivati dihidroksiheksanoinske kiseline - Google Patents

Novi derivati dihidroksiheksanoinske kiseline

Info

Publication number
YU47100A
YU47100A YU47100A YU47100A YU47100A YU 47100 A YU47100 A YU 47100A YU 47100 A YU47100 A YU 47100A YU 47100 A YU47100 A YU 47100A YU 47100 A YU47100 A YU 47100A
Authority
YU
Yugoslavia
Prior art keywords
acid derivatives
dihydroxahexanoic
novel
useful
general formula
Prior art date
Application number
YU47100A
Other languages
English (en)
Inventor
John Charles Kath
Matthew Frank Brown
Christopher Stanley Poss
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of YU47100A publication Critical patent/YU47100A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)

Abstract

Novi derivati dihidroksiheksanoinske kiseline opšte formule su primenljivi u tretiranju inflamacije i drugih imunih poremećaja.[Dihydroxyhexanoic acid derivatives of general formula are useful to treat inflammation and other immune disorders.
YU47100A 1998-02-05 1999-01-18 Novi derivati dihidroksiheksanoinske kiseline YU47100A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7380198P 1998-02-05 1998-02-05

Publications (1)

Publication Number Publication Date
YU47100A true YU47100A (sh) 2002-11-15

Family

ID=22115885

Family Applications (1)

Application Number Title Priority Date Filing Date
YU47100A YU47100A (sh) 1998-02-05 1999-01-18 Novi derivati dihidroksiheksanoinske kiseline

Country Status (37)

Country Link
EP (1) EP1051405B1 (sh)
JP (1) JP3693916B2 (sh)
KR (1) KR100385529B1 (sh)
CN (1) CN1177834C (sh)
AP (1) AP992A (sh)
AR (1) AR016175A1 (sh)
AT (1) ATE337307T1 (sh)
AU (1) AU752407B2 (sh)
BG (1) BG104726A (sh)
BR (1) BR9907655A (sh)
CA (1) CA2320388C (sh)
DE (1) DE69932920T2 (sh)
DZ (1) DZ2717A1 (sh)
EA (1) EA003137B1 (sh)
ES (1) ES2268847T3 (sh)
GT (1) GT199900011A (sh)
HK (1) HK1034969A1 (sh)
HR (1) HRP20000529B1 (sh)
HU (1) HUP0100832A3 (sh)
IL (1) IL137330A0 (sh)
IS (1) IS5562A (sh)
MA (1) MA26603A1 (sh)
MY (1) MY133125A (sh)
NO (1) NO20003965D0 (sh)
NZ (1) NZ505724A (sh)
OA (1) OA11448A (sh)
PA (1) PA8467301A1 (sh)
PE (1) PE20000243A1 (sh)
PL (1) PL342817A1 (sh)
SK (1) SK11262000A3 (sh)
TN (1) TNSN99013A1 (sh)
TR (1) TR200002248T2 (sh)
TW (1) TW470744B (sh)
UA (1) UA57824C2 (sh)
WO (1) WO1999040061A2 (sh)
YU (1) YU47100A (sh)
ZA (1) ZA99873B (sh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002535358A (ja) * 1999-01-29 2002-10-22 ミレニアム・ファーマシューティカルズ・インコーポレイテッド 移植片拒絶反応及び虚血−再灌流障害の予防方法
PL205059B1 (pl) * 1999-08-20 2010-03-31 Dow Agrosciences Llc Heterocykliczny amid aromatyczny, jego kompozycja grzybobójcza oraz sposób zwalczania lub zapobiegania zakażeniom grzybami
EP1498417A1 (en) * 2000-02-04 2005-01-19 Pfizer Products Inc. Heterocyclic amide derivatives
PL357094A1 (en) * 2000-02-04 2004-07-12 Pfizer Products Inc. Heterocyclic amide derivatives
US6740636B2 (en) * 2000-07-31 2004-05-25 Schering Aktiengesellschaft Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection
US6746856B2 (en) 2000-08-09 2004-06-08 Pfizer Inc. Microbial conversion of bicyclic heteroaromatic compounds
CZ20033456A3 (en) 2001-06-22 2004-07-14 Pfizer Products Inc. Pharmaceutical compositions comprising adsorbates of amorphous drug
ATE444060T1 (de) 2001-06-22 2009-10-15 Pfizer Prod Inc Pharmazeutische zusammensetzungen enthaltend dispersionen aus arzneistoffen und neutralen polymeren
EP1269994A3 (en) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmaceutical compositions comprising drug and concentration-enhancing polymers
DE10152351B4 (de) * 2001-10-18 2005-09-22 Schering Ag Feste Arzneimittelformulierung für ein Piperazinharnstoffderivat
EP1469832B2 (en) 2002-02-01 2016-10-26 Bend Research, Inc. Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials
RU2004133530A (ru) * 2002-05-14 2005-06-10 Пфайзер Продактс Инк. (Us) Производные дигидроксигексановой кислоты, их промежуточные соединения и способы получения
BR0309932A (pt) * 2002-05-14 2005-02-09 Pfizer Prod Inc Métodos para a fabricação de derivados de diidro-furan-2-ona
MXPA05000977A (es) 2002-08-12 2005-05-16 Pfizer Prod Inc Composiciones farmaceuticas de farmacos semiordenados y polimeros.
BR0313378A (pt) * 2002-08-12 2005-07-12 Pfizer Producs Inc Formas cristalinas da [4carbamoil-1-(3-fluorobenzil)-2,7-dihidróxi-7-metil-o ctil]-amida do ácido quinoxalina-2-carboxìlico
US20040097554A1 (en) * 2002-10-30 2004-05-20 Pfizer Inc Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents
US20040087571A1 (en) * 2002-10-30 2004-05-06 Pfizer Inc Methods of using CCR1 antagonists as immunomodulatory agents
BRPI0413277A (pt) 2003-08-04 2006-10-10 Pfizer Prod Inc composições farmacêuticas de adsorvatos de medicamentos amorfos e materiais que formam microfases lipofìlicas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923864A (en) * 1987-12-15 1990-05-08 Pfizer Inc. Certain heterocyclic-hexanamides useful for treating hypertension
ES2180600T3 (es) * 1994-10-19 2003-02-16 Novartis Ag Eteres de isosteros substrato de aspartato proteasa antivirales.
DE19708106A1 (de) * 1997-02-28 1998-09-03 Bosch Gmbh Robert Einrichtung und Verfahren zur Information über Verkehrsstörungen

Also Published As

Publication number Publication date
EP1051405A2 (en) 2000-11-15
NO20003965D0 (no) 2000-08-04
SK11262000A3 (sk) 2001-01-18
JP2002502839A (ja) 2002-01-29
CN1290255A (zh) 2001-04-04
AR016175A1 (es) 2001-06-20
AU1778999A (en) 1999-08-23
HRP20000529B1 (en) 2004-12-31
IL137330A0 (en) 2001-07-24
TW470744B (en) 2002-01-01
NZ505724A (en) 2003-02-28
AU752407B2 (en) 2002-09-19
HK1034969A1 (en) 2001-11-09
DE69932920D1 (de) 2006-10-05
ZA99873B (en) 2000-08-04
MY133125A (en) 2007-10-31
AP992A (en) 2001-08-06
JP3693916B2 (ja) 2005-09-14
DE69932920T2 (de) 2007-02-08
OA11448A (en) 2003-11-18
TNSN99013A1 (fr) 2005-11-10
AP9901457A0 (en) 1999-03-31
BG104726A (en) 2001-04-30
UA57824C2 (uk) 2003-07-15
GT199900011A (es) 2000-07-20
DZ2717A1 (fr) 2003-09-01
HUP0100832A2 (hu) 2002-02-28
KR20010040684A (ko) 2001-05-15
EA200000741A1 (ru) 2001-02-26
ATE337307T1 (de) 2006-09-15
CN1177834C (zh) 2004-12-01
EP1051405B1 (en) 2006-08-23
TR200002248T2 (tr) 2000-12-21
EA003137B1 (ru) 2003-02-27
WO1999040061A3 (en) 1999-10-21
WO1999040061A2 (en) 1999-08-12
IS5562A (is) 2000-07-14
ES2268847T3 (es) 2007-03-16
BR9907655A (pt) 2000-10-24
MA26603A1 (fr) 2004-12-20
HUP0100832A3 (en) 2002-03-28
HRP20000529A2 (en) 2001-08-31
KR100385529B1 (ko) 2003-05-27
PE20000243A1 (es) 2000-04-07
PL342817A1 (en) 2001-07-02
CA2320388A1 (en) 1999-08-12
PA8467301A1 (es) 2000-05-24
CA2320388C (en) 2005-05-03
NO20003965L (sh) 2000-10-03

Similar Documents

Publication Publication Date Title
MY121294A (en) Novel hexanoic acid derivatives.
YU47100A (sh) Novi derivati dihidroksiheksanoinske kiseline
IL112495A0 (en) Phenylacetic acid derivatives, their preparation and compositions containing them
IL129068A0 (en) Sulfinic acid derivatives and their preparation and use
HK1049671A1 (en) Substituted indoles.
TW352384B (en) Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals
PT1190713E (pt) Inibicao dos intermediarios de produtos finais de glicosilacao avancada e pos-amadori.
HK1047582A1 (en) Substituted benzimidazole.
HK1012554A1 (en) Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
MY138140A (en) N-aroylphenylalanine derivatives
WO1993000330A3 (en) Azanorbornane derivatives
TW225534B (sh)
ZA9710796B (en) Oxyiminopregnanecarbolactones.
MY109722A (en) Azaoxindole derivatives.
DE69723863D1 (de) Chinoline und deren therapeutische verwendung
UA49884C2 (uk) ПОХІДНІ <font face="Symbol">a</font>-ГІДРОКСИКАРБОНОВОЇ КИСЛОТИ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
IL150125A0 (en) Novel compounds
AU4179399A (en) Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
MX9603348A (es) Derivados de disulfuro de amida indano-2-mercaptoacetilica novedosos utiles como inhibidores de encefalinasa.
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання
ZA983231B (en) Substituted benzyloxyimino compounds.
MX9700113A (es) Amido-quinoxalindionas novedosas, su preparacion y uso.
FR2421894A1 (fr) Nouvelles 2,3-dihydro-4h-1-benzopyranne-4-one-o-carbamoyloximes utiles notamment comme inhibiteurs de secretion gastrique
MX9704677A (es) Procedimientos novedosos para preparar intermediarios de inhibidores de encefalinasa y enzima de conversion a angiotensina y sus intermediarios.
MXPA02004704A (es) Analogos de acido hidroxieicosatetraenoico y sus metodos de uso en el tratamiento de trastornos de resequedad del ojo.